Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective

Detalhes bibliográficos
Autor(a) principal: Moura, AL
Data de Publicação: 2019
Outros Autores: Pereira, C, Regateiro, FS, Azevedo, J, Todo Bom, A, Carrapatoso, I
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.4/2354
Resumo: Introduction. Sublingual immunotherapy (SLIT) with Pru p 3 can prevent severe allergic reactions to LTP-containing foods, but the standard initiation protocol is time-consuming. Objectives. Establish the safety of a novel ultra-rush initiation protocol for SLIT with Pru p 3. Methods. Prospective study comparing the side effects of the standard vs novel ultra-rush initiation protocols of SLIT with Pru p 3 in patients with anaphylaxis to LTP. Results. Fifteen patients were included (standard initiation, 5; ultra-rush initiation, 10), 80% females. All patients had oropharyngeal pruritus during initiation, 80% with spontaneous recovery, but no other gastro-intestinal, respiratory, cutaneous or systemic side effects occurred in any patient of both groups. Conclusion. The novel ultra-rush protocol halved the build-up time without increasing side effects.
id RCAP_1d1fb81ec47402728ce1b3f69516a606
oai_identifier_str oai:rihuc.huc.min-saude.pt:10400.4/2354
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effectiveHipersensibilidade AlimentarImunoterapia SublingualIntroduction. Sublingual immunotherapy (SLIT) with Pru p 3 can prevent severe allergic reactions to LTP-containing foods, but the standard initiation protocol is time-consuming. Objectives. Establish the safety of a novel ultra-rush initiation protocol for SLIT with Pru p 3. Methods. Prospective study comparing the side effects of the standard vs novel ultra-rush initiation protocols of SLIT with Pru p 3 in patients with anaphylaxis to LTP. Results. Fifteen patients were included (standard initiation, 5; ultra-rush initiation, 10), 80% females. All patients had oropharyngeal pruritus during initiation, 80% with spontaneous recovery, but no other gastro-intestinal, respiratory, cutaneous or systemic side effects occurred in any patient of both groups. Conclusion. The novel ultra-rush protocol halved the build-up time without increasing side effects.RIHUCMoura, ALPereira, CRegateiro, FSAzevedo, JTodo Bom, ACarrapatoso, I2024-02-20T16:00:00Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.4/2354engEur Ann Allergy Clin Immunol . 2019 Sep 16;51(5):206-212.10.23822/EurAnnACI.1764-1489.99info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T08:49:21Zoai:rihuc.huc.min-saude.pt:10400.4/2354Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:10:45.157405Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
title Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
spellingShingle Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
Moura, AL
Hipersensibilidade Alimentar
Imunoterapia Sublingual
title_short Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
title_full Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
title_fullStr Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
title_full_unstemmed Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
title_sort Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
author Moura, AL
author_facet Moura, AL
Pereira, C
Regateiro, FS
Azevedo, J
Todo Bom, A
Carrapatoso, I
author_role author
author2 Pereira, C
Regateiro, FS
Azevedo, J
Todo Bom, A
Carrapatoso, I
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv RIHUC
dc.contributor.author.fl_str_mv Moura, AL
Pereira, C
Regateiro, FS
Azevedo, J
Todo Bom, A
Carrapatoso, I
dc.subject.por.fl_str_mv Hipersensibilidade Alimentar
Imunoterapia Sublingual
topic Hipersensibilidade Alimentar
Imunoterapia Sublingual
description Introduction. Sublingual immunotherapy (SLIT) with Pru p 3 can prevent severe allergic reactions to LTP-containing foods, but the standard initiation protocol is time-consuming. Objectives. Establish the safety of a novel ultra-rush initiation protocol for SLIT with Pru p 3. Methods. Prospective study comparing the side effects of the standard vs novel ultra-rush initiation protocols of SLIT with Pru p 3 in patients with anaphylaxis to LTP. Results. Fifteen patients were included (standard initiation, 5; ultra-rush initiation, 10), 80% females. All patients had oropharyngeal pruritus during initiation, 80% with spontaneous recovery, but no other gastro-intestinal, respiratory, cutaneous or systemic side effects occurred in any patient of both groups. Conclusion. The novel ultra-rush protocol halved the build-up time without increasing side effects.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019-01-01T00:00:00Z
2024-02-20T16:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.4/2354
url http://hdl.handle.net/10400.4/2354
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur Ann Allergy Clin Immunol . 2019 Sep 16;51(5):206-212.
10.23822/EurAnnACI.1764-1489.99
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137757959815168